Therapeutic effect and safety of second-line treatment of anlotinib combined with paclitaxel for injection(albumin bound) on advanced driving gene negative non-small cell lung cancer

Xu Shanshan; Shi Zhenshan; Wang Qiangqiang; Lan Feng; Su Fang

doi:10.3760/j.issn.1673-4777.2021.06.010

Home>Articles>Therapeutic effect and safety of second-line treatment of anlotinib combined with paclitaxel for injection(albumin bound) on advanced driving gene negative non-small cell lung cancer

DOI: 10.3760/j.issn.1673-4777.2021.06.010

Therapeutic effect and safety of second-line treatment of anlotinib combined with paclitaxel for injection(albumin bound) on advanced driving gene negative non-small cell lung cancer

Xu Shanshan

Shi Zhenshan

Wang Qiangqiang

Lan Feng

Su Fang

Machine-generated Keywords：

Publication Date：2021-06-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：4( 841-844 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2021,16(6)